From: A method for exposing rodents to resuspended particles using whole-body plethysmography
 | Chamber 1 | Chamber 2 | Chamber 3 | Chamber 4 | Chamber 5 | Chamber 6 | Average | RSDa |
---|---|---|---|---|---|---|---|---|
Phase 1 | ||||||||
Day 0 | 0.620 | 0.486 | 1.022 | 0.526 | 0.310 | 0.551 | 0.586 | 40.6% |
Day 1 | 0.867 | 0.656 | 0.848 | 0.617 | 0.575 | 0.447 | 0.668 | 24.3% |
Day 2 | 0.973 | 0.634 | 0.656 | 0.765 | 0.860 | 0.763 | 0.775 | 16.4% |
Day 3 | 1.497 | 0.686 | 0.919 | 0.856 | 1.158 | 1.285 | 1.067 | 28.2% |
Average | 0.989 | 0.616 | 0.861 | 0.691 | 0.726 | 0.761 | 0.774 | -- |
RSD | 37.3% | 14.4% | 17.9% | 21.4% | 50.3% | 49.0% | -- | 35.5% |
Phase 2 | ||||||||
Day 0 | 2.473 | 1.201 | 1.701 | 1.427 | 1.568 | 1.456 | 1.638 | 27.0% |
Day 1 | 1.706 | 1.671 | 1.601 | 2.111 | 1.986 | 1.175 | 1.708 | 19.2% |
Day 2 | 0.926 | 1.513 | 1.902 | 1.627 | 1.849 | --b | 1.563 | 25.0% |
Day 3 | 1.496 | 2.062 | 1.832 | 1.529 | 1.244 | 2.135 | 1.716 | 20.4% |
Average | 1.650 | 1.612 | 1.759 | 1.674 | 1.662 | 1.589 | 1.657 | -- |
RSD | 38.8% | 22.2% | 7.63% | 18.1% | 19.8% | 31.1% | -- | 21.6% |
Phase 3 | ||||||||
Day 0 | 1.214 | 2.677 | 5.425 | 2.971 | 2.283 | 2.634 | 2.867 | 48.6% |
Day 1 | 2.715 | 1.973 | 4.406 | 2.997 | 1.141 | 2.740 | 2.662 | 41.0% |
Day 2 | 1.287 | 1.902 | 3.038 | 1.941 | 1.152 | 2.287 | 1.935 | 35.6% |
Day 3 | 1.457 | 4.739 | 1.602 | 2.050 | 2.279 | 1.510 | 2.273 | 55.1% |
Average | 1.668 | 2.823 | 3.618 | 2.490 | 1.714 | 2.293 | 2.434 | -- |
RSD | 42.3% | 46.9% | 45.9% | 23.0% | 38.2% | 24.3% | -- | 46.1% |
Phase 4 | ||||||||
Day 0 | 1.780 | 1.783 | 2.661 | 3.038 | 1.762 | 3.673 | 2.450 | 32.9% |